Nascent Biotech Inc.
BURNSVILLE, MN · CIK 0001622057 · Biotech · Public
Monoclonal antibody therapeutic (Pritimumab) targeting rare cancers
nascentbiotech.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $543K
- 1 Form D · Oct 2014
- 144 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 3 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $542,500 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2594 | Collidion Inc. | — | $575K |
| 2595 | Animantis LLC | — | $550K |
| 2596 | EVRYS BIO LLC | — | $548K |
| 2597 | Nascent Biotech Inc. | — | $543K |
| 2598 | Mitochondria in Motion, Inc. | — | — |
| 2599 | SKYRAN BIOLOGICS, INC. | — | — |
| 2600 | Aurora Bio, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sean CarrickDirector · Executive Officer
- Mark GlassyDirector · Executive Officer
- Lowell HoldenDirector · Executive Officer
- Brandon PriceDirector · Executive Officer
Patents
- Kits And Containers For Treating Vimentin Expressing Tumorsgranted
- Kits And Containers For Treating Vimentin Expressing Tumorsgranted
- Enhanced Delivery Of Drugs To The Brainapplication
- Enhanced Delivery Of Drugs To The Braingranted
- Enhanced Delivery Of Drugs To The Brainapplication
- Kits And Containers For Treating Vimentin Expressing Tumorsapplication
- Enhanced Delivery Of Drugs To The Brainapplication
- Enhanced Delivery Of Drugs To The Brainapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.